Recombinant Human GRO2 Protein

Product Discontinued

Recombinant Human GRO2 Protein Summary

• Description: CXCL2 (Human) Recombinant Protein
  
  Source: E. coli
  
  Amino Acid Sequence: APLATELRCQCLQTLQGIHLKNIQSVKVKSPGPHCAQTEVIATLKNGQKACLNPASPMVKKIIEKMLKNGKSN
• Preparation Method: Escherichia coli expression system
• Details of Functionality: The activity is determined by the ability to chemoattract purified human neutrophils and is detectable starting at 10 ng/mL.
• Protein/Peptide Type: Recombinant Protein
• Gene: CXCL2

Applications/Dilutions

• Dilutions:
  • Functional
  • SDS-Page
• Application Notes: This product is useful for Func,SDS-PAGE.

Reactivity Notes

Human

Packaging, Storage & Formulations

• Storage: Store at -20C. Avoid freeze-thaw cycles.
• Buffer: No additive Reconstitute with sterilized water.
• Preservative: No Preservative

Notes

This product is produced by and distributed for Abnova, a company based in Taiwan.

Alternate Names for Recombinant Human GRO2 Protein

• chemokine (C-X-C motif) ligand 2
• CINC-2a
• GRO2 oncogene
• GRO2MIP2
• GROb
• gro-beta
• Growth-regulated protein beta
• Macrophage inflammatory protein 2-alpha
• melanoma growth stimulatory activity beta
• MGSA beta
• MGSA-b
• MIP-2a
• MIP2AC-X-C motif chemokine 2
• SCYB2MIP2-alpha

Background

Produced by activated monocytes and neutrophils and expressed at sites of inflammation. Hematoregulatorychemokine, which, in vitro, suppresses hematopoietic progenitor cell proliferation. GRO-beta(5-73) shows a highlyenhanced hematopoietic activity

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Bioinformatics

• Gene Symbol: CXCL2